Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages-Reference-Cited by-同舟云学术

Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages

Published:2018-08-10 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Deshmukh Sachin Kumar,Tyagi Nikhil,Khan Mohammad Aslam,Srivastava Sanjeev Kumar,Al-Ghadhban Ahmed,Dugger Kari,Carter James Elliot,Singh Seema,Singh Ajay Pratap

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-30437-2.pdf

Reference40 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J Clin 67, 7–30 (2017).

2. Sun, H., Ma, H., Hong, G., Sun, H. & Wang, J. Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981-2010. Sci Rep 4, 6747 (2014).

3. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74, 2913–2921 (2014).

4. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J Clin 68, 7–30 (2018).

5. Moore, M. J. et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25, 1960–1966 (2007).

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting tumor-associated macrophages to reverse antitumor drug resistance;Aging;2024-05-23

2. The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer;Cancer Medicine;2024-05

3. Targeting macrophages for pancreatic cancer therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024

4. Immunogenic chemotherapy: great potential for improving response rates;Frontiers in Oncology;2023-12-06

5. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies;Cancer Letters;2023-10